메뉴 건너뛰기




Volumn 9, Issue 12, 2013, Pages 1173-1183

Predictors of progression to Type 1 diabetes: Preparing for immune interventions in the preclinical disease phase

Author keywords

Anti CD3; Autoantibodies; C peptide; HLA; Hyperglycemic clamp; OGTT; Prediction; Prevention; Proinsulin; Type 1 diabetes

Indexed keywords

ABATACEPT; AUTOANTIBODY; AUTOANTIGEN; C PEPTIDE; CASEIN HYDROLYSATE; CD20 ANTIBODY; CD3 ANTIBODY; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 65; HEMOGLOBIN A1C; HLA A24 ANTIGEN; HLA B18 ANTIGEN; HLA B39 ANTIGEN; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; INDOLEACETIC ACID; INSULIN; INTERLEUKIN 1BETA; ISLET ANTIGEN 2; MICRORNA 375; NICOTINAMIDE; OTELIXIZUMAB; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR 1; PROINSULIN; RITUXIMAB; TEPLIZUMAB; UNCLASSIFIED DRUG; ZINC TRANSPORTER; ZINC TRANSPORTER 8A;

EID: 84887859536     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/1744666X.2013.856757     Document Type: Article
Times cited : (18)

References (95)
  • 1
    • 84871941957 scopus 로고    scopus 로고
    • Diagnosis and classification of diabetes mellitus
    • American Diabetes Association
    • American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 36(Suppl. 1), S67-S74 (2013
    • (2013) Diabetes Care , vol.36 S67-S74 , Issue.SUPPL. 1
  • 2
    • 0027370108 scopus 로고
    • The effect of intensive treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus
    • The Diabetes Control and Complications Trial Research Group
    • The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329, 977-986 (1993
    • (1993) N. Engl. J. Med , vol.329 , pp. 977-986
  • 3
    • 84887899377 scopus 로고    scopus 로고
    • Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: A multicenter prospective registration study
    • EURODIAB Study Group
    • Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G, EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: A multicenter prospective registration study. Lancet 376, 259-266 (2009
    • (2009) Lancet , vol.376 , pp. 259-266
    • Patterson, C.C.1    Dahlquist, G.G.2    Gyürüs, E.3    Green, A.4    Soltész, G.5
  • 4
    • 0036580691 scopus 로고    scopus 로고
    • The incidence of type 1 diabetes in the age group 0-39 years has not increased in antwerp (belgium) between 1989 and 2000: Evidence for earlier disease manifestation
    • Belgian Diabetes Registry
    • Weets I, De Leeuw I, Du Caju M et al.; Belgian Diabetes Registry. The incidence of type 1 diabetes in the age group 0-39 years has not increased in Antwerp (Belgium) between 1989 and 2000: Evidence for earlier disease manifestation. Diabetes Care 25, 840-846 (2002
    • (2002) Diabetes Care , vol.25 , pp. 840-846
    • Weets, I.1    De Leeuw, I.2    Du Caju, M.3
  • 6
    • 0034816754 scopus 로고    scopus 로고
    • Prospects for predicting and stopping the development of type 1 diabetes
    • Belgian Diabetes Registry
    • Gorus F, Pipeleers D; Belgian Diabetes Registry. Prospects for predicting and stopping the development of type 1 diabetes. Best Pract. Res. Clin. Endocrinol. Metab. 15, 371-389 (2001
    • (2001) Best Pract. Res. Clin. Endocrinol. Metab , vol.15 , pp. 371-389
    • Gorus, F.1    Pipeleers, D.2
  • 7
    • 84887016461 scopus 로고    scopus 로고
    • Prevention versus intervention of type 1 diabetes
    • doi:10.1016/j.clim.2013.05.018 Epub ahead of print
    • Brooks-Worrell B, Palmer JP. Prevention versus intervention of type 1 diabetes. Clin. Immunol. doi:10.1016/j.clim.2013.05.018 (2013) (Epub ahead of print
    • (2013) Clin. Immunol
    • Brooks-Worrell, B.1    Palmer, J.P.2
  • 8
    • 84872708324 scopus 로고    scopus 로고
    • Primary and secondary prevention in type 1 diabetes
    • Skyler JS. Primary and secondary prevention in type 1 diabetes. Diabet. Med. 30, 161-169 (2013
    • (2013) Diabet. Med , vol.30 , pp. 161-169
    • Skyler, J.S.1
  • 9
    • 31844443761 scopus 로고    scopus 로고
    • The rise and fall of insulin secretion in type 1 diabetes
    • Tsai EB, Sherry NA, Palmer JP, Herold KC. The rise and fall of insulin secretion in type 1 diabetes. Diabetologia 49, 261-270 (2006
    • (2006) Diabetologia , vol.49 , pp. 261-270
    • Tsai, E.B.1    Sherry, N.A.2    Palmer, J.P.3    Herold, K.C.4
  • 10
    • 78751662679 scopus 로고    scopus 로고
    • Type 1 diabetes: Etiology, immunology and therapeutic strategies
    • Van Belle TL, Coppieters KT, von Herrath MG. Type 1 diabetes: Etiology, immunology and therapeutic strategies. Physiol. Rev. 91, 79-119 (2011
    • (2011) Physiol. Rev , vol.91 , pp. 79-119
    • Van Belle, T.L.1    Coppieters, K.T.2    Von Herrath, M.G.3
  • 11
    • 20544443927 scopus 로고    scopus 로고
    • Insulin needs following CD3-antibody therapy in new-onset type 1 diabetes
    • Keymeulen B, Vandemeulebroucke E, Ziegler A et al. Insulin needs following CD3-antibody therapy in new-onset type 1 diabetes. N. Engl. J. Med. 352, 2598-2608 (2005
    • (2005) N. Engl. J. Med , vol.352 , pp. 2598-2608
    • Keymeulen, B.1    Vandemeulebroucke, E.2    Ziegler, A.3
  • 12
    • 0027078251 scopus 로고
    • Pancreatic beta cells in insulin-dependent diabetes
    • Pipeleers D, Ling Z. Pancreatic beta cells in insulin-dependent diabetes. Diabetes Metab. Rev. 8, 209-227 (1992
    • (1992) Diabetes Metab. Rev , vol.8 , pp. 209-227
    • Pipeleers, D.1    Ling, Z.2
  • 13
    • 9644280863 scopus 로고    scopus 로고
    • Age-dependent influences on the origins of autoimmune diabetes: Evidence and implications
    • Leslie RD, Delli Castelli M. Age-dependent influences on the origins of autoimmune diabetes: Evidence and implications. Diabetes 53, 3033-3040 (2004
    • (2004) Diabetes , vol.53 , pp. 3033-3040
    • Leslie, R.D.1    Delli Castelli, M.2
  • 14
    • 78149475225 scopus 로고    scopus 로고
    • Dietary intervention in infancy and later signs of beta-cell autoimmunity
    • Knip M, Virtanen SM, Seppä K et al. Dietary intervention in infancy and later signs of beta-cell autoimmunity. N. Engl. J. Med. 363, 1900-1908 (2010
    • (2010) N. Engl. J. Med , vol.363 , pp. 1900-1908
    • Knip, M.1    Virtanen, S.M.2    Seppä, K.3
  • 15
    • 0037198427 scopus 로고    scopus 로고
    • Effects of insulin in relatives of patients with type 1 diabetes mellitus
    • Diabetes Prevention Trial - Type 1 Diabetes Study Group
    • Diabetes Prevention Trial - Type 1 Diabetes Study Group. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N. Engl. J. Med. 346, 1685-1691 (2002
    • (2002) N. Engl. J. Med , vol.346 , pp. 1685-1691
  • 16
    • 70349257206 scopus 로고    scopus 로고
    • Belgian diabetes registry insulin treatment in ia-2 antibody positive relatives of type 1 diabetic patients
    • Vandemeulebroucke E, Gorus F, Decochez K et al.; Belgian Diabetes Registry. Insulin treatment in IA-2 antibody positive relatives of type 1 diabetic patients. Diabetes Metab. 35, 319-327 (2009
    • (2009) Diabetes Metab , vol.35 , pp. 319-327
    • Vandemeulebroucke, E.1    Gorus, F.2    Decochez, K.3
  • 17
    • 19444366641 scopus 로고    scopus 로고
    • Intervening before the onset of type 1 diabetes: Results of the european nicotinamide diabetes intervention trial (endit
    • The ENDIT group
    • The ENDIT group. Intervening before the onset of type 1 diabetes: Results of the european Nicotinamide diabetes intervention trial (ENDIT). Lancet 363, 925-931 (2004
    • (2004) Lancet , vol.363 , pp. 925-931
  • 18
    • 55749104546 scopus 로고    scopus 로고
    • Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: A double blind, randomized controlled trial
    • Näntö-Salonen K, Kupila A, Simell S et al. Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: A double blind, randomized controlled trial. Lancet 372, 1746-1755 (2008
    • (2008) Lancet , vol.372 , pp. 1746-1755
    • Näntö-Salonen, K.1    Kupila, A.2    Simell, S.3
  • 19
    • 78751482758 scopus 로고    scopus 로고
    • Stopping type 1 diabetes: Attempts to prevent or cure type 1 diabetes in man
    • Skyler JS, Ricordi C. Stopping type 1 diabetes: Attempts to prevent or cure type 1 diabetes in man. Diabetes 60 1-8 (2011
    • (2011) Diabetes , vol.60 , pp. 1-8
    • Skyler, J.S.1    Ricordi, C.2
  • 20
    • 80052900429 scopus 로고    scopus 로고
    • A historical view from thirty eventful years of immunotherapy in autoimmune diabetes
    • Bach JF, Chatenoud L. A historical view from thirty eventful years of immunotherapy in autoimmune diabetes. Sem. Immunol. 23, 174-181 (2011
    • (2011) Sem. Immunol , vol.23 , pp. 174-181
    • Bach, J.F.1    Chatenoud, L.2
  • 21
    • 0037198420 scopus 로고    scopus 로고
    • Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
    • Herold KC, Hagopian W, Auger JA et al. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N. Engl. J. Med. 346, 1692-1698 (2002
    • (2002) N. Engl. J. Med , vol.346 , pp. 1692-1698
    • Herold, K.C.1    Hagopian, W.2    Auger, J.A.3
  • 22
    • 70449480577 scopus 로고    scopus 로고
    • Rituximab B-lymphocyte depletion and preservation of beta cell function
    • Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H et al. Rituximab, B-lymphocyte depletion and preservation of beta cell function. N. Engl. J. Med. 361, 2143-2152 (2009
    • (2009) N. Engl. J. Med , vol.361 , pp. 2143-2152
    • Pescovitz, M.D.1    Greenbaum, C.J.2    Krause-Steinrauf, H.3
  • 23
    • 79960912796 scopus 로고    scopus 로고
    • Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: A randomized, double-blind, placebo-controlled trial
    • Orban T, Bundy B, Becker DJ et al. Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: A randomized, double-blind, placebo-controlled trial. Lancet 378, 412-419 (2011
    • (2011) Lancet , vol.378 , pp. 412-419
    • Orban, T.1    Bundy, B.2    Becker, D.J.3
  • 24
    • 55249110198 scopus 로고    scopus 로고
    • GAD treatment and insulin secretion in recent-onset type 1 diabetes
    • Ludvigsson J, Faresjö M, Hjorth M et al. GAD treatment and insulin secretion in recent-onset type 1 diabetes. N. Engl. J. Med. 359, 1909-1920 (2008
    • (2008) N. Engl. J. Med , vol.359 , pp. 1909-1920
    • Ludvigsson, J.1    Faresjö, M.2    Hjorth, M.3
  • 25
    • 0035944844 scopus 로고    scopus 로고
    • Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (diapep 277): A randomized, double-blind, phase ii trial
    • Raz I, Elias D, Avron A, Tamin M, Metzger M, Cohen IR. Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep 277): A randomized, double-blind, phase II trial. Lancet 358, 1749-1753 (2001
    • (2001) Lancet , vol.358 , pp. 1749-1753
    • Raz, I.1    Elias, D.2    Avron, A.3    Tamin, M.4    Metzger, M.5    Cohen, I.R.6
  • 26
    • 77949266510 scopus 로고    scopus 로고
    • Four-year metabolic outcome of a randomized controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass
    • Keymeulen B, Walter M, Mathieu C et al. Four-year metabolic outcome of a randomized controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass. Diabetologia 53, 614-623 (2010
    • (2010) Diabetologia , vol.53 , pp. 614-623
    • Keymeulen, B.1    Walter, M.2    Mathieu, C.3
  • 27
    • 33751228149 scopus 로고    scopus 로고
    • Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell grafts
    • Keymeulen B, Gillard P, Mathieu C et al. Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell grafts. Proc. Natl Acad. Sci. USA 103, 17444-17449 (2006
    • (2006) Proc. Natl Acad. Sci. USA , vol.103 , pp. 17444-17449
    • Keymeulen, B.1    Gillard, P.2    Mathieu, C.3
  • 28
    • 79960088916 scopus 로고    scopus 로고
    • Insulitis in human type 1 diabetes
    • Veld P. Insulitis in human type 1 diabetes. Islets 3, 131-138 (2011
    • (2011) Islets , vol.3 , pp. 131-138
    • Veld, P.1
  • 29
    • 0031408561 scopus 로고    scopus 로고
    • Diabetes registries and early biological markers of insulin-dependent diabetes mellitus
    • Gorus FK. Diabetes registries and early biological markers of insulin-dependent diabetes mellitus. Belgian Diabetes Registry. Diabetes Metab. Rev. 13, 247-274 (1997
    • (1997) Belgian Diabetes Registry. Diabetes Metab. Rev , vol.13 , pp. 247-274
    • Gorus, F.K.1
  • 30
    • 0036144926 scopus 로고    scopus 로고
    • Relative and absolute HLA DQA1-DQB1-linked risk for developing type 1 diabetes before age 40 years in the Belgian population: Implications for future prevention studies
    • Belgian Diabetes Registry
    • Van Der Auwera B, Van Autreve J, Schuit F, Weets I, Ivens A, Gorus F; Belgian Diabetes Registry. Relative and absolute HLA DQA1-DQB1-linked risk for developing type 1 diabetes before age 40 years in the Belgian population: Implications for future prevention studies. Hum. Immunol. 63, 40-50 (2002
    • (2002) Hum. Immunol , vol.63 , pp. 40-50
    • Van Der Auwera, B.1    Van Autreve, J.2    Schuit, F.3    Weets, I.4    Ivens, A.5    Gorus, F.6
  • 31
    • 0030850319 scopus 로고    scopus 로고
    • Epidemiology, clinical aspects and biology of IDDM under age 40 years comparison of data from antwerp with complete ascertainment with those from belgium with 40% ascertainment
    • Vandewalle C, Coeckelberghs M, De Leeuw I et al. Epidemiology, clinical aspects and biology of IDDM under age 40 years. Comparison of data from Antwerp with complete ascertainment with those from Belgium with 40% ascertainment. Diabetes Care 20, 1556-1561 (1997
    • (1997) Diabetes Care , vol.20 , pp. 1556-1561
    • Vandewalle, C.1    Coeckelberghs, M.2    De Leeuw, I.3
  • 32
    • 72449167381 scopus 로고    scopus 로고
    • Hyperglycaemic clamp test for diabetes risk assessment in IA-2 antibody positive relatives of type 1 diabetic patients
    • Belgian Diabetes Registry
    • Vandemeulebroucke E, Keymeulen B, Decochez K et al.; Belgian Diabetes Registry. Hyperglycaemic clamp test for diabetes risk assessment in IA-2 antibody positive relatives of type 1 diabetic patients. Diabetologia 53, 36-44 (2010
    • (2010) Diabetologia , vol.53 , pp. 36-44
    • Vandemeulebroucke, E.1    Keymeulen, B.2    Decochez, K.3
  • 34
    • 84857073801 scopus 로고    scopus 로고
    • Reduced prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes in young children participating in longitudinal follow-up
    • Elding Larsson H, Vehik K, Bell R et al. Reduced prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes in young children participating in longitudinal follow-up. Diabetes Care 34, 2347-2352 (2011
    • (2011) Diabetes Care , vol.34 , pp. 2347-2352
    • Elding Larsson, H.1    Vehik, K.2    Bell, R.3
  • 35
    • 0030953692 scopus 로고    scopus 로고
    • The limitations of clinical trials for prevention of IDDM
    • Mahon JL, Dupré J. The limitations of clinical trials for prevention of IDDM. Diabetes Care 20, 1027-1033 (1997
    • (1997) Diabetes Care , vol.20 , pp. 1027-1033
    • Mahon, J.L.1    Dupré, J.2
  • 36
    • 34948899336 scopus 로고    scopus 로고
    • Estimation of ß-cell mass by metabolic tests necessary, but how efficient?
    • Robertson RP. Estimation of ß-cell mass by metabolic tests. Necessary, but how efficient? Diabetes 56, 2420-2424 (2007
    • (2007) Diabetes , vol.56 , pp. 2420-2424
    • Robertson, R.P.1
  • 38
    • 77949273351 scopus 로고    scopus 로고
    • Predictive power of screening for antibodies against IA-2(beta) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: Implications for prevention trials
    • Belgian Diabetes Registry
    • De Grijse J, Asanghanwa M, Nouthé B et al.; Belgian Diabetes Registry. Predictive power of screening for antibodies against IA-2(beta) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: Implications for prevention trials. Diabetologia 53, 517-524 (2010
    • (2010) Diabetologia , vol.53 , pp. 517-524
    • De Grijse, J.1    Asanghanwa, M.2    Nouthé, B.3
  • 39
    • 84870442527 scopus 로고    scopus 로고
    • Screening for IA-2 and zinc transporter 8 autoantibodies: A cost-effective strategy to identify relatives of type 1 diabetic patients with a high and age-independent progression rate to clinical onset
    • Belgian Diabetes Registry
    • Gorus F, Balti E, Vermeulen I et al.; Belgian Diabetes Registry. Screening for IA-2 and zinc transporter 8 autoantibodies: A cost-effective strategy to identify relatives of type 1 diabetic patients with a high and age-independent progression rate to clinical onset. Clin. Exp. Immunol. 171, 82-90 (2013
    • (2013) Clin. Exp. Immunol , vol.171 , pp. 82-90
    • Gorus, F.1    Balti, E.2    Vermeulen, I.3
  • 40
    • 80051471700 scopus 로고    scopus 로고
    • Teplizumab for treatment of type 1 diabetes (protégé study): 1-year results from a randomized, placebo-controlled trial
    • Sherry N, Hagopian W, Ludvigsson J et al. Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomized, placebo-controlled trial. Lancet 378, 487-497 (2011
    • (2011) Lancet , vol.378 , pp. 487-497
    • Sherry, N.1    Hagopian, W.2    Ludvigsson, J.3
  • 41
    • 0021019885 scopus 로고
    • Insulin antibodies in insulin-dependent diabetics before insulin treatment
    • Palmer JP, Asplin CM, Clemons P et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222, 1337-1339 (1983
    • (1983) Science , vol.222 , pp. 1337-1339
    • Palmer, J.P.1    Asplin, C.M.2    Clemons, P.3
  • 42
    • 0025039679 scopus 로고
    • Identification of the 64k autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase
    • Baekkeskov S, Aanstoot HJ, Christgau S et al. Identification of the 64k autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347, 151-156 (1990
    • (1990) Nature , vol.347 , pp. 151-156
    • Baekkeskov, S.1    Aanstoot, H.J.2    Christgau, S.3
  • 43
    • 0029975769 scopus 로고    scopus 로고
    • IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus
    • Lan MS, Wasserfall C, Maclaren NK, Notkins AL. IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc. Natl Acad. Sci. USA 93, 6367-6370 (1996
    • (1996) Proc. Natl Acad. Sci. USA , vol.93 , pp. 6367-6370
    • Lan, M.S.1    Wasserfall, C.2    MacLaren, N.K.3    Notkins, A.L.4
  • 44
    • 36749011882 scopus 로고    scopus 로고
    • The cation efflux transporter ZnT8 (Slc 30A8) is a major autoantigen in human type 1 diabetes
    • Wenzlau JM, Juhl K, Yu L et al. The cation efflux transporter ZnT8 (Slc 30A8) is a major autoantigen in human type 1 diabetes. Proc. Natl Acad. Sci. USA 104, 17040-17045 (2007
    • (2007) Proc. Natl Acad. Sci. USA , vol.104 , pp. 17040-17045
    • Wenzlau, J.M.1    Juhl, K.2    Yu, L.3
  • 45
    • 0029995958 scopus 로고    scopus 로고
    • Prediction of type 1 diabetes in first-degree relatives using a combination of insulin GAD, and ICA512bdc/IA-2 autoantibodies
    • Verge CF, Gianani R, Kawasaki E et al. Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45, 926-933 (1996
    • (1996) Diabetes , vol.45 , pp. 926-933
    • Verge, C.F.1    Gianani, R.2    Kawasaki, E.3
  • 46
    • 10544222424 scopus 로고    scopus 로고
    • Anti islet autoantibodies usually develop sequentially rather than simultaneously
    • Yu L, Rewers M, Gianini R et al. Anti islet autoantibodies usually develop sequentially rather than simultaneously. J. Clin. Endocrinol. Metab. 81, 4264-4267 (1996
    • (1996) J. Clin. Endocrinol. Metab , vol.81 , pp. 4264-4267
    • Yu, L.1    Rewers, M.2    Gianini, R.3
  • 47
    • 84856732408 scopus 로고    scopus 로고
    • An important minority of prediabetic first-degree relatives of type 1 diabetic patients derives from seroconversion to persistent antibody-positivity after age 10
    • Belgian Diabetes Registry
    • Vermeulen I, Weets I, Costa O et al.; Belgian Diabetes Registry. An important minority of prediabetic first-degree relatives of type 1 diabetic patients derives from seroconversion to persistent antibody-positivity after age 10. Diabetologia 55, 413-420 (2012
    • (2012) Diabetologia , vol.55 , pp. 413-420
    • Vermeulen, I.1    Weets, I.2    Costa, O.3
  • 50
    • 77951891703 scopus 로고    scopus 로고
    • Prediction and pathogenesis in type 1 diabetes
    • Ziegler AG, Nepom GT. Prediction and pathogenesis in type 1 diabetes. Immunity 32, 468-478 (2010
    • (2010) Immunity , vol.32 , pp. 468-478
    • Ziegler, A.G.1    Nepom, G.T.2
  • 51
    • 0036460367 scopus 로고    scopus 로고
    • IA-2 autoantibodies predict impending type 1 diabetes in siblings of patients
    • Belgian Diabetes Registry
    • Decochez K, De Leeuw IH, Keymeulen B et al.; Belgian Diabetes Registry. IA-2 autoantibodies predict impending type 1 diabetes in siblings of patients. Diabetologia 45, 1658-1666 (2002
    • (2002) Diabetologia , vol.45 , pp. 1658-1666
    • Decochez, K.1    De Leeuw, I.H.2    Keymeulen, B.3
  • 52
    • 84879114358 scopus 로고    scopus 로고
    • Seroconversion to multiple islet autoantibodies and risk to progression to diabetes in children
    • Ziegler AG, Rewers M, Simell O et al. Seroconversion to multiple islet autoantibodies and risk to progression to diabetes in children. JAMA 309, 2473-2479 (2013
    • (2013) JAMA , vol.309 , pp. 2473-2479
    • Ziegler, A.G.1    Rewers, M.2    Simell, O.3
  • 53
    • 77951926420 scopus 로고    scopus 로고
    • Etiology of type 1 diabetes
    • Todd JA. Etiology of type 1 diabetes. Immunity 32, 457-467 (2010
    • (2010) Immunity , vol.32 , pp. 457-467
    • Todd, J.A.1
  • 54
    • 20944431720 scopus 로고    scopus 로고
    • Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes
    • Belgian Diabetes Registry
    • Decochez K, Truyen I, Van Der Auwera B et al.; Belgian Diabetes Registry. Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes. Diabetologia 48, 687-694 (2005
    • (2005) Diabetologia , vol.48 , pp. 687-694
    • Decochez, K.1    Truyen, I.2    Van Der Auwera, B.3
  • 55
    • 84875411051 scopus 로고    scopus 로고
    • HLA-A.*24 is an independent predictor of 5-year progression to diabetes in autoantibody positive first-degree relatives of type 1 diabetic patients
    • Belgian Diabetes Registry
    • Mbunwe E, Van Der Auwera B, Vermeulen I et al.; Belgian Diabetes Registry. HLA-A. *24 is an independent predictor of 5-year progression to diabetes in autoantibody positive first-degree relatives of type 1 diabetic patients. Diabetes 62, 1345-1350 (2013
    • (2013) Diabetes , vol.62 , pp. 1345-1350
    • Mbunwe, E.1    Van Der Auwera, B.2    Vermeulen, I.3
  • 56
    • 84881614925 scopus 로고    scopus 로고
    • In autoantibody-positive first-degree relatives of patients with type 1 diabetes, HLA-A*24 and HLA-B*18 -but not HLA-B*39 -are predictors of impending diabetes with distinct HLA-DQ interactions
    • Belgian Diabetes Registry
    • Mbunwe E, Van Der Auwera B, Weets I et al.; Belgian Diabetes Registry. In autoantibody-positive first-degree relatives of patients with type 1 diabetes, HLA-A*24 and HLA-B*18 -but not HLA-B*39 -are predictors of impending diabetes with distinct HLA-DQ interactions. Diabetologia 56, 1964-1970 (2013
    • (2013) Diabetologia , vol.56 , pp. 1964-1970
    • Mbunwe, E.1    Van Der Auwera, B.2    Weets, I.3
  • 57
    • 43649106996 scopus 로고    scopus 로고
    • Extreme genetic risk for type 1A diabetes in the post-genome era
    • Baschal EE, Eisenbarth GS. Extreme genetic risk for type 1A diabetes in the post-genome era. J. Autoimmun. 31, 1-6 (2008
    • (2008) J. Autoimmun , vol.31 , pp. 1-6
    • Baschal, E.E.1    Eisenbarth, G.S.2
  • 58
    • 78650057803 scopus 로고    scopus 로고
    • Effect of HLA class i and class II alleles in progression form autoantibody positivity to overt type 1 diabetes in children with risk-associated class II genotypes
    • Lipponen K, Gombos Z, Kiviniemi M et al. Effect of HLA class I and class II alleles in progression form autoantibody positivity to overt type 1 diabetes in children with risk-associated class II genotypes. Diabetes 59, 3253-3256 (2010
    • (2010) Diabetes , vol.59 , pp. 3253-3256
    • Lipponen, K.1    Gombos, Z.2    Kiviniemi, M.3
  • 59
    • 84875453617 scopus 로고    scopus 로고
    • Prediction of type 1 diabetes
    • Erlich HA, Valdes AM, Noble J. Prediction of type 1 diabetes. Diabetes 62, 1020-2021 (2013
    • (2013) Diabetes , vol.62 , pp. 1020-2021
    • Erlich, H.A.1    Valdes, A.M.2    Noble, J.3
  • 60
    • 84857396075 scopus 로고    scopus 로고
    • Effects of non-HLA gene polymorphisms or development of islet autoimmunity and type 1 diabetes in a population with high-risk HLA-DR
    • Steck AK, Wong R, Wagner B et al. Effects of non-HLA gene polymorphisms or development of islet autoimmunity and type 1 diabetes in a population with high-risk HLA-DR, DQ genotypes. Diabetes 61, 753-758 (2012
    • (2012) DQ Genotypes. Diabetes , vol.61 , pp. 753-758
    • Steck, A.K.1    Wong, R.2    Wagner, B.3
  • 61
    • 84867741377 scopus 로고    scopus 로고
    • A strategy for combining minor genetic susceptibility genes to improve prediction of disease in type 1 diabetes
    • Winkler C, Krumsich J, Lempainen J et al. A strategy for combining minor genetic susceptibility genes to improve prediction of disease in type 1 diabetes. Genes Immun. 13, 549-555 (2012
    • (2012) Genes Immun , vol.13 , pp. 549-555
    • Winkler, C.1    Krumsich, J.2    Lempainen, J.3
  • 62
    • 84859545808 scopus 로고    scopus 로고
    • Effect of PTPN22 and INS risk genotypes on the progression to clinical type 1 diabetes after initiation of ß-cell autoimmunity
    • Lempainen J, Hermann R, Veijola R, Simell O, Knip M, Ilonen J. Effect of PTPN22 and INS risk genotypes on the progression to clinical type 1 diabetes after initiation of ß-cell autoimmunity. Diabetes 61, 963-966 (2012
    • (2012) Diabetes , vol.61 , pp. 963-966
    • Lempainen, J.1    Hermann, R.2    Veijola, R.3    Simell, O.4    Knip, M.5    Ilonen, J.6
  • 63
    • 84878847275 scopus 로고    scopus 로고
    • Characteristics of rapid vs slow progression to type 1 diabetes in multiple autoantibody-positive children
    • Achenbach P, Hummel M, Thümer L, Boerschmann H, Höfelmann D, Ziegler AG. Characteristics of rapid vs. slow progression to type 1 diabetes in multiple autoantibody-positive children. Diabetologia 56, 1615-1622 (2013
    • (2013) Diabetologia , vol.56 , pp. 1615-1622
    • Achenbach, P.1    Hummel, M.2    Thümer, L.3    Boerschmann, H.4    Höfelmann, D.5    Ziegler, A.G.6
  • 64
    • 0028989040 scopus 로고
    • HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet cell antibody positive first-degree relatives of patients with IDDM
    • Pugliese A, Gianani R, Moromisato R et al. HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet cell antibody positive first-degree relatives of patients with IDDM. Diabetes 44, 608-613 (1995
    • (1995) Diabetes , vol.44 , pp. 608-613
    • Pugliese, A.1    Gianani, R.2    Moromisato, R.3
  • 65
    • 0029006991 scopus 로고
    • DRB1*0403 protects against IDDM in Caucasians with the high risk heterozygous DQA1*0301-DQB1*0302/DQA1*0501-DQB1*0201 genotype
    • Belgian Diabetes Registry
    • Van Der Auwera B, Van Waeyenberge C, Schuit F et al.; Belgian Diabetes Registry. DRB1*0403 protects against IDDM in Caucasians with the high risk heterozygous DQA1*0301-DQB1*0302/DQA1*0501-DQB1*0201 genotype. Diabetes 44, 527-530 (1995
    • (1995) Diabetes , vol.44 , pp. 527-530
    • Van Der Auwera, B.1    Van Waeyenberge, C.2    Schuit, F.3
  • 66
    • 27744498867 scopus 로고    scopus 로고
    • Proinsulin level and proinsulin-to-C-peptide ratio complement autoantibody measurement for predicting type 1 diabetes
    • Belgian Diabetes Registry
    • Truyen I, De Pauw P, Jørgensen P et al.; Belgian Diabetes Registry. Proinsulin level and proinsulin-to-C-peptide ratio complement autoantibody measurement for predicting type 1 diabetes. Diabetologia 48, 2322-2329 (2005
    • (2005) Diabetologia , vol.48 , pp. 2322-2329
    • Truyen, I.1    De Pauw, P.2    Jørgensen, P.3
  • 67
    • 84881614660 scopus 로고    scopus 로고
    • The use of intermediate endpoints in the design of type 1 diabetes prevention trials
    • Type 1 Diabetes Trial Net Study Group
    • Krischer JP; Type 1 Diabetes Trial Net Study Group. The use of intermediate endpoints in the design of type 1 diabetes prevention trials. Diabetologia 56, 1919-1924 (2013
    • (2013) Diabetologia , vol.56 , pp. 1919-1924
    • Krischer, J.P.1
  • 69
    • 0023926801 scopus 로고
    • Between and within subject variation of the first phase insulin response to intravenous glucose
    • Smith CP, Tarn AC, Thomas JM et al. Between and within subject variation of the first phase insulin response to intravenous glucose. Diabetologia 31, 123-125 (1988
    • (1988) Diabetologia , vol.31 , pp. 123-125
    • Smith, C.P.1    Tarn, A.C.2    Thomas, J.M.3
  • 70
    • 84866652634 scopus 로고    scopus 로고
    • Prognostic accuracy of immunologic and metabolic markers for type 1 diabetes in a high-risk population: Receiver operating characteristic analysis
    • DPT-1 Study Group
    • Xu P, Beam CA, Cuthberson D, Sosenko JM, Skyler JS, Krischer JP; DPT-1 Study Group. Prognostic accuracy of immunologic and metabolic markers for type 1 diabetes in a high-risk population: Receiver operating characteristic analysis. Diabetes Care 35, 1975-1980 (2012
    • (2012) Diabetes Care , vol.35 , pp. 1975-1980
    • Xu, P.1    Beam, C.A.2    Cuthberson, D.3    Sosenko, J.M.4    Skyler, J.S.5    Krischer, J.P.6
  • 71
    • 55249085210 scopus 로고    scopus 로고
    • Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta cell function in therapeutic trials in type 1 diabetes
    • Type 1 Diabetes Trial Net Research Group; European C-Peptide Trial Study Group
    • Greenbaum CJ, Mandrup-Poulson T, Mc Gee PF et al.; Type 1 Diabetes Trial Net Research Group; European C-Peptide Trial Study Group. Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta cell function in therapeutic trials in type 1 diabetes. Diabetes Care 31, 1966-1971 (2008
    • (2008) Diabetes Care , vol.31 , pp. 1966-1971
    • Greenbaum, C.J.1    Mandrup-Poulson, T.2    Mc Gee, P.F.3
  • 72
    • 0018520840 scopus 로고
    • Glucose clamp technique: A method for quantifying insulin secretion and resistance
    • De Fronzo RA, Tobin JD, Andres R. Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am. J. Physiol. 237, E214-E223 (1979
    • (1979) Am. J. Physiol , vol.237
    • De Fronzo, R.A.1    Tobin, J.D.2    Andres, R.3
  • 73
    • 0028607474 scopus 로고
    • Disproportionally elevated proinsulin levels precede the onset of insulin-dependent diabetes mellitus in siblings with low first-phase insulin responses
    • The Childhood Diabetes in Finland Study Group
    • Røder ME, Knip M, Hartling SG, Karjalainen J, A ́ kerblom HK, Binder C. Disproportionally elevated proinsulin levels precede the onset of insulin-dependent diabetes mellitus in siblings with low first-phase insulin responses. The Childhood Diabetes in Finland Study Group. J. Clin. Endocrinol. Metab. 79, 1570-1575 (1994
    • (1994) J. Clin. Endocrinol. Metab , vol.79 , pp. 1570-1575
    • Røder, M.E.1    Knip, M.2    Hartling, S.G.3    Karjalainen, J.4    Ákerblom, H.K.5    Binder, C.6
  • 74
    • 0031791047 scopus 로고    scopus 로고
    • Disproportionally elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus
    • Røder ME, Porte DJ, Schwartz RS, Kahn SE. Disproportionally elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 83, 604-608 (1998
    • (1998) J. Clin. Endocrinol. Metab , vol.83 , pp. 604-608
    • Røder, M.E.1    Porte, D.J.2    Schwartz, R.S.3    Kahn, S.E.4
  • 75
    • 0033347050 scopus 로고    scopus 로고
    • Prolonged exposure of human beta cells to high glucose increased their release of proinsulin during acute stimulation with glucose or arginine
    • Hostens K, Ling Z, Van Schravendijk C, Pipeleers DG. Prolonged exposure of human beta cells to high glucose increased their release of proinsulin during acute stimulation with glucose or arginine. J. Clin. Endocrino.l Metab. 84, 1386-1390 (1999
    • (1999) J. Clin. Endocrinol Metab , vol.84 , pp. 1386-1390
    • Hostens, K.1    Ling, Z.2    Van Schravendijk, C.3    Pipeleers, D.G.4
  • 76
    • 0032740992 scopus 로고    scopus 로고
    • Exposure of human islets to cytokines can result in disproportionally elevated proinsulin release
    • Hostens K, Pavolovic D, Zambre Y et al. Exposure of human islets to cytokines can result in disproportionally elevated proinsulin release. J. Clin. Invest. 104, 67-72 (1999
    • (1999) J. Clin. Invest , vol.104 , pp. 67-72
    • Hostens, K.1    Pavolovic, D.2    Zambre, Y.3
  • 77
    • 57149084533 scopus 로고    scopus 로고
    • Simultaneous determination of plasma concentrations of proinsulin C-peptide, and their ratio with a trefoil-type time-resolved fluorescence immunoassay
    • De Pauw P, Vermeulen I, Ubani O et al. Simultaneous determination of plasma concentrations of proinsulin, C-peptide, and their ratio with a trefoil-type time-resolved fluorescence immunoassay. Clin. Chem. 54, 1990-1998 (2008
    • (2008) Clin. Chem , vol.54 , pp. 1990-1998
    • De Pauw, P.1    Vermeulen, I.2    Ubani, O.3
  • 78
    • 0027309516 scopus 로고
    • Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation
    • Lampeter EF, Homberg M, Quabeck K et al. Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet 341, 1243-1244 (1993
    • (1993) Lancet , vol.341 , pp. 1243-1244
    • Lampeter, E.F.1    Homberg, M.2    Quabeck, K.3
  • 79
    • 0035807589 scopus 로고    scopus 로고
    • Development of type 1 diabetes despite severe hereditary B-lymphocyte deficiency
    • Martin S, Wolf-Eichbaum D, Duinkerken G et al. Development of type 1 diabetes despite severe hereditary B-lymphocyte deficiency. N. Engl. J. Med. 345, 1036-1040 (2001
    • (2001) N. Engl. J. Med , vol.345 , pp. 1036-1040
    • Martin, S.1    Wolf-Eichbaum, D.2    Duinkerken, G.3
  • 80
    • 84887026167 scopus 로고    scopus 로고
    • Biomarkers for immune intervention trials in type 1 diabetes
    • doi:10.1016/j.clim.2013.02.009 Epub ahead of print
    • Mallone R, Roep BO. Biomarkers for immune intervention trials in type 1 diabetes. Clin. Immunol. doi:10.1016/j.clim.2013.02.009 (2013) (Epub ahead of print
    • (2013) Clin. Immunol
    • Mallone, R.1    Roep, B.O.2
  • 81
    • 85047690395 scopus 로고    scopus 로고
    • Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health
    • Arif S, Tree TI, Astill TP et al. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J. Clin. Invest. 113, 451-463 (2004
    • (2004) J. Clin. Invest , vol.113 , pp. 451-463
    • Arif, S.1    Tree, T.I.2    Astill, T.P.3
  • 82
    • 82255183367 scopus 로고    scopus 로고
    • Single insulin-specific CD8+ T cells show characteristic gene expression profiles in human type 1 diabetes
    • Luce S, Lemonnier F, Briand JP et al. Single insulin-specific CD8+ T cells show characteristic gene expression profiles in human type 1 diabetes. Diabetes 60, 3289-3299 (2011
    • (2011) Diabetes , vol.60 , pp. 3289-3299
    • Luce, S.1    Lemonnier, F.2    Briand, J.P.3
  • 83
    • 43049150180 scopus 로고    scopus 로고
    • Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation
    • Huurman VA, Hilbrands R, Pinkse GG et al. Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation. PLoS ONE 3, e2435 (2008
    • (2008) PLoS ONE , vol.3
    • Huurman, V.A.1    Hilbrands, R.2    Pinkse, G.G.3
  • 84
    • 70349635504 scopus 로고    scopus 로고
    • Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients
    • Hilbrands R, Huurman VA, Gillard P et al. Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients. Diabetes 58, 2267-2276 (2009
    • (2009) Diabetes , vol.58 , pp. 2267-2276
    • Hilbrands, R.1    Huurman, V.A.2    Gillard, P.3
  • 85
    • 79953220761 scopus 로고    scopus 로고
    • Evidence that nasal insulin induces immune tolerance to insulin in adults with autoimmune diabetes
    • Fourlanos S, Perry C, Gellert SA et al. Evidence that nasal insulin induces immune tolerance to insulin in adults with autoimmune diabetes. Diabetes 60, 1237-1245 (2011
    • (2011) Diabetes , vol.60 , pp. 1237-1245
    • Fourlanos, S.1    Perry, C.2    Gellert, S.A.3
  • 86
    • 84861868291 scopus 로고    scopus 로고
    • Through the fog: Recent clinical trials to preserve b-cell function in type 1 diabetes
    • Greenbaum CJ, Schatz DA, Haller MJ et al. Through the fog: Recent clinical trials to preserve b-cell function in type 1 diabetes. Diabetes 61, 1323-1330 (2012
    • (2012) Diabetes , vol.61 , pp. 1323-1330
    • Greenbaum, C.J.1    Schatz, D.A.2    Haller, M.J.3
  • 87
    • 34548397755 scopus 로고    scopus 로고
    • Screening for insulitis in autoantibody-positive non-diabetic organ donors
    • Veld P, Lievens D, De Grijse J et al. Screening for insulitis in autoantibody-positive non-diabetic organ donors. Diabetes 56, 2400-2404 (2007
    • (2007) Diabetes , vol.56 , pp. 2400-2404
    • Veld, P.1    Lievens, D.2    De Grijse, J.3
  • 88
    • 84867041203 scopus 로고    scopus 로고
    • Network for pancreatic organ donors with diabetes (nPOD): Developing a tissue biobank for type 1 diabetes
    • Campbell-Thompson M, Wasserfall C, Kaddis J et al. Network for pancreatic organ donors with diabetes (nPOD): Developing a tissue biobank for type 1 diabetes. Diabetes Metab. Res. Rev. 28(7), 608-617 (2012
    • (2012) Diabetes Metab. Res. Rev , vol.28 , Issue.7 , pp. 608-617
    • Campbell-Thompson, M.1    Wasserfall, C.2    Kaddis, J.3
  • 89
    • 33846238106 scopus 로고    scopus 로고
    • Species and epitope specificity of two 65 kDa glutamate decarboxylase time resolved fluorometric immunoassays
    • Rui M, Hampe C, Wang C et al. Species and epitope specificity of two 65 kDa glutamate decarboxylase time resolved fluorometric immunoassays. J. Immunol. Methods 319, 133-143 (2007
    • (2007) J. Immunol. Methods , vol.319 , pp. 133-143
    • Rui, M.1    Hampe, C.2    Wang, C.3
  • 90
    • 84887862212 scopus 로고    scopus 로고
    • Potential of protein phosphatase inhibitor 1 as biomarker of pancreatic beta cell injury in vitro and in vivo
    • Jiang L, Brackeva B, Ling Z et al. Potential of protein phosphatase inhibitor 1 as biomarker of pancreatic beta cell injury in vitro and in vivo. Diabetes 62, 2683-2688 (2013
    • (2013) Diabetes , vol.62 , pp. 2683-2688
    • Jiang, L.1    Brackeva, B.2    Ling, Z.3
  • 91
    • 79952378639 scopus 로고    scopus 로고
    • Detection of beta cell death in diabetes using differentially methylated circulating DNA
    • Akirav EM, Lebastchi J, Galvan EM et al. Detection of beta cell death in diabetes using differentially methylated circulating DNA. Diabetes 60, 876-883 (2011
    • (2011) Diabetes , vol.60 , pp. 876-883
    • Akirav, E.M.1    Lebastchi, J.2    Galvan, E.M.3
  • 92
  • 94
    • 84861868035 scopus 로고    scopus 로고
    • The metabolic progression to type 1 diabetes as indicated by serial oral glucose tolerance testing in the diabetes prevention trial-type 1
    • Type 1 Diabetes TrialNet and Diabetes Prevention Trial-Type 1 Study Groups
    • Sosenko JM, Skyler JS, Herold KC, Palmer JP; Type 1 Diabetes TrialNet and Diabetes Prevention Trial-Type 1 Study Groups. The metabolic progression to type 1 diabetes as indicated by serial oral glucose tolerance testing in the Diabetes Prevention Trial-type 1. Diabetes 61, 1331-1337 (2012
    • (2012) Diabetes , vol.61 , pp. 1331-1337
    • Sosenko, J.M.1    Skyler, J.S.2    Herold, K.C.3    Palmer, J.P.4
  • 95
    • 57749176852 scopus 로고    scopus 로고
    • Type 1 diabetes trialnet -an international collaborative clinical trials network
    • Skyler JS, Greenbaum CJ, Lachin JM et al.; Type 1 Diabetes TrialNet -An international collaborative clinical trials network. Ann. NY Acad. Sci. 1150, 14-24 (2008
    • (2008) Ann. NY Acad. Sci , vol.1150 , pp. 14-24
    • Skyler, J.S.1    Greenbaum, C.J.2    Lachin, J.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.